Asian Journal of Pharmaceutics

2007 | 6,102,844 words

The Asian Journal of Pharmaceutics (AJP), published by BRNSS Publication Hub & Mandsaur University, is an open-access, international, English-language journal issuing four editions annually since 2007. Dedicated to advancing pharmaceutical and related sciences, AJP offers a global platform for researchers to showcase their work and inspire innovati...

Triphala Described as an Antidiabetic Agent in Ayurveda Treatises: A Review

Author(s):

K. R. C. Reddy


Read the Summary


Download the PDF file of the original publication


Year: 2017 | Doi: 10.22377/ajp.v11i04.1696

Copyright (license): Creative Commons Attribution 4.0 International (CC BY 4.0) license.


[[[ p. 1 ]]]

[Summary: This page introduces Triphala as an antidiabetic agent in Ayurveda. It summarizes Triphala's role in treating Prameha (diabetes), referencing formulations in Charaka Samhita, Sushruta Samhita, and others. Dosage forms like Churna and Kwath are mentioned. It highlights the need for safer hypoglycemic agents due to the side effects of modern treatments.]

Asian Journal of Pharmaceutic s • Oct-Dec 2017 (Suppl) • 11 (4) | S 685 Triphala Described as an Antidiabetic Agent in Ayurveda Treatises: A Review Chandra Shekhar, K. R. C. Reddy, Komal Bansal Department of Rasashastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India Abstract Triphala is a well-known traditional ayurvedic formulation which is most commonly used to tone up and support the normal functioning of the bowel Many traditional compounds containing Triphala as an ingredient, is found to be useful in the treatment of several kinds of ailments and diabetes is among one of them. Triphala has been described elaborately in Ayurveda for the treatment of Prameha (diabetes). In this present paper, an attempt has been made to summarize the antidiabetic potential of Triphala as a whole as well as the impact of individual drugs of Triphala. In present paper antidiabetic potential of this formulation is complied. In, Charaka Samhita 7 (30.4%), Sushruta Samhita 4 (17.4%) Astanga Samgraha 2 (8.7%), Vrinda Madhav 4 (17.4%), Gada Nigraha 4 (17.4%), and Chakradatta 2 (8.7%) formulations are described which possess Triphala as ingredient for antidiabetic action. Triphala has been used widely in different dosage forms. 1 formulation in the form of Swaras/rasa (4.3%), 4 as Churna (17.4%), 13 as Kwath/Kashaya (57.0%), 2 as Gutika/Guggulu (8.7%), 1 as Kshaar (4.3%), and 2 in the form of Avasa and Arishta (8.4%) Keywords: Antidiabetic agent, Ayurveda, Prameha, Pramehahar, Triphala Address for correspondence: Prof. K. R. C. Reddy, Department of Rasashastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi - 221 005, Uttar Pradesh, India. E-mail: drkrcreddybhu@yahoo.co.in Received: 03-11-2017 Revised: 21-11-2017 Accepted: 28-11-2017 INTRODUCTION N owadays, Prameha is recognized as annoyance lifestyle disorder in the society. Although Prameha is considered as a single disease entity, in real sense it provides space for flourishment of many notorious and incurable diseases with due course of time. Various complications related to the kidney damage (nephropathy), cardiovascular diseases, nerve damage (neuropathy), eye damage (retinopathy), foot damage, hearing impairments, skin worse conditions, etc., [1] in a person suffering from diabetes for a longer duration. Long-term usage of many contemporary therapies for diabetes including insulin injections, various oral antidiabetic agents such as sulfonylureas, biguanides, and glinides are also some other factors which are responsible for generating a number of serious ill effects on the vital organs of a diabetic person. Hence, it is the need of hour to develop some safer, effective and therapeutically more potent alternative hypoglycemic agents which are competent enough to treat the symptoms and complications associated with diabetes mellitus Usage of traditional medicines (TM) is now being accepted worldwide for its therapeutic benefits for many diseases and also for diabetes mellitus [2] In TM even a single herb or formulation contains many phytochemical constituents such as alkaloids, terpenoids, and flavonoids which alone or in conjunction with one another synergistically exhibits desired pharmacological action [3] There are no known drug interactions with the three herbal ingredients of Triphala . Hence, administration of any other antidiabetic drugs with Triphala is safer as compared to other formulations, which do not possess it [4] Intake of Triphala is considered to be gentle to human body, so it can be administered to the people of all age groups [5] In this present paper, an attempt has been made to summarize the extraneous outstanding potential of three fruits (dry fruits of Haritaki, Vibhitaki, and Amalaki which is collectively called Triphala) in cursing disease of today’s time, i.e., Prameha which is explained elaborately in numerous ayurvedic treatises [Table 1] REVIEW AR TICLE

[[[ p. 2 ]]]

[Summary: This page defines Prameha and its types according to Ayurveda. It describes Triphala's composition (Harar, Bahera, Amla) and its various health benefits beyond diabetes, such as colon cleansing and cholesterol reduction. The page mentions Brihatrayee and other texts as sources for Triphala formulations indicated for Prameha.]

Shekhar, et al .: Triphala: An antidiabetic agent Asian Journal of Pharmaceutic s • Oct-Dec 2017 (Suppl) • 11 (4) | S 686 PRAMEHA Prameha is well described in the ancient literature, i.e. in Vedas and in the Ayurveda. Premeha is a syndrome which includes a group of clinical conditions and mainly characterized by increased quantity of turbid urine, described in classics as “Prabhuta Avila Mutrata.” [6] Polyuria and Turbidity of the urine are the two essential features of this particular disease [7] Some of the ayurvedic scholars have quoted that the word Prameha comprises a list of urinary disorders which may be characterized by abundant urination due to severe imbalances of Dosha and Dushyas [8] Two main types of Prameha are described in Ayurveda – Sahaja (refers to natural, inherited or congenital factors) and Doshaja (refers to Dosha vitiation). Based on the clinical importance it is further divided into two types - Sthoola Prameha (urinary disorders of stouts) and Krisha Prameha (urinary disorders of lean [9] Diabetes Mellitus is similar to Madhumeha which is one among the Vataja Prameha. In which the patient voids excessive quantity of urine having Madhura Rasa, Ruksha Sparsha, and Kashaya Varna [10] TRIPHALA Triphala is an important ayurvedic herbal formulation consisting of the dried fruits of three medicinal plants Terminalia chebula , Terminalia bellerica , and Emblica officinalis Triphala means “three” (tri) “fruits” (phala) and are popularly known in India as Harar, Bahera, and Amla, respectively [11] The formulation is prescribed as the first line of treatment of many aliments as a detoxifying agent and rejuvenator. Apart from the formulation, the individual herbs also reported to have dozens of other health benefits such as laxative in chronic constipation, colon cleansing, digestive disturbances, ophthalmic disorders, hypertensive diseases, serum cholesterol reduction, hepatic abnormalities, enteritis, and ulcerative colitis [12] But along with these therapeutic activities, it has a wide range of description for the management of different kinds of Prameha in the ayurvedic literature [Table 2] either individually or in combination with some other formulations The most valuable treasures of Ayurveda including Brihatrayee (Charaka Samhita, Sushruta Samhita, and Astanga Samgraha), Rasa Granthas (Vrinda Madhav), Nighantu (Gada Nigraha), and Chakradatta were filtered out for the formulations having Triphala as a whole or in parts and especially indicated for Prameha Pramehahar properties of Triphala in Ayurveda Pramehahar (antidiabetic) formulations having Triphala as the main ingredient are very well defined in Brihatrayee especially in the chapters dealing with the treatment of Prameha. In Charaka Samhita total 7 (30.4%), Sushruta Samhita 4 (17.4%), Astanga Samgraha 2 (8.7%), Vrinda Madhav 4 (17.4%), Gada Nigraha 4 (17.4%), and Chakradatta 2 (8.7%) formulations are there containing Triphala as ingredient for antidiabetic action. Total 13 (57.0%) formulations contains more than 50% of Triphala, while 10 (43.0%) possesses <50% of Triphala as the main ingredients. On screening out the above texts it was found that at four places usage of only Triphala (100%) in the form of kwath (decoction) and churna (powder) has been prescribed for the patient suffering from Prameha [Table 2] Researches validation about antidiabetic potentials of Triphala Haritaki is known to possess antidiabetic effect as its aqueous extract on oral administration can improve glucose utilization Table 1: General description and pharmacodynamic properties of Haritaki, Bibhitaki, and Amalaki [13] Description Haritaki Bibhitaki Amalaki Latin name Terminalia chebula Linn Terminalia bellerica Roxb Emblica officinalis Gartn Family Combretaceae Combretaceae Euphorbiaceae Common synonyms Haritaki, Pathya, Abhaya, Avyatha, Vayastha, Shiva Aksha, Kaliphala, Bhutavasa, Kalidruma, Karnaphala Amalaki, Dhatri, Vyastha English name Chebulic Myrobalan Belleric Myrobalan Emblic myrobalan Parts used Fruits Fruits Fruits Rasa Pancharasa (Lavana Rahita), Kashaya Pradhan Pancharasa (Lavana Rahita), Kashaya Pradhan Pancharasa (Lavana Rahita), Amla Pradhan Guna Laghu, Ruksha Laghu, Ruksha Laghu, Ruksha, Sita Virya Ushna Ushna Sita Vipaka Madhura Madhura Madhura Prabhava Tridosha hara Tridosha hara Tridosha hara Dosha karma Visheshatah Kapha pitta Samaka Visheshatah Kapha hara Visheshatah Pitta hara Chemical composition Tannin, chebulic acid, gallic acid, Coliragin Tannin, B‑sitosterol, gallic acid, tannic acid, ellagic acid Gallic acid, tannic acid, albumin, Vitamin C

[[[ p. 3 ]]]

[Summary: This page discusses the antidiabetic effects of individual Triphala components like Haritaki and Amalaki. It mentions Haritaki's renoprotective effects and Amalaki's ability to protect pancreatic alpha cells. Bibhitaki's role in removing phlegm is also noted. The page also mentions the different dosage forms such as Swaras and Churna.]

Shekhar, et al .: Triphala: An antidiabetic agent Asian Journal of Pharmaceutic s • Oct-Dec 2017 (Suppl) • 11 (4) | S 687 during glucose tolerant test (46.8% reduction in blood glucose at 2 h) within 90 min after administration of the extract and also brings down the fasting blood sugar to near the normal value in 2 weeks from an initial high value of 253 + 9.4 mg/dl [24] Diabetic nephropathy is one of the complications associated with diabetes mellitus in chronic stage and Haritaki in its chloroform extract form produces renoprotective effects in STZ induced diabetic rats [2] Apart from antidiabetic activities, it is also helpful in curing the diseases associated with imbalance of all the three Doshas, i.e., Vata, Pitta, and Kapha, stimulating digestion and promoting longevity [25] Similarly, Amalaki ( E. officinalis ) is known to be effective in the long-term treatment of Prameha and it also could protect the alpha cells of pancreas from oxidative stress and make them to function properly, with the extraneous advantage of modulating the lipid profile [26] It is also used for urinary tract dysfunctioning such as painful urination and conditions which tends to be difficulty in micturition [27] It has Ushan Virya (i.e., cooling effect) that manages Pitta, further supporting the liver to perform its natural functions natural functions and also boost up the immune system. E. officinalis extract has been shown to reduce liver injury and prevents from hepatotoxicity [28,29] In the line of various medicinal impacts of Haritaki and Amalaki, Bibhitaki also exhibits antidiabetic effect and most commonly it is used for the removal of excessive phlegm deposited in respiratory tract via acting as bronchodilator, and also removes Kapha deposited in urinary tract such as stones [30] DISCUSSION Triphala is an esteemed drug in ayurvedic system of medicines which has been prescribed for centuries to cure a wide range of ailments. As it is a polyherbal formulation, thus it exhibits a different mechanism of action from that of synthetic drugs or single substances. And looking out on all the above formulations, it was observed that Triphala has been used widely in different dosage forms such as 1 formulation in the form of Swaras/rasa (4.3%), 4 as Churna (17.4%), 13 as Kwath/Kashaya (57.0%), 2 as Gutika/Guggulu (8.7%), 1 as Kshaar (4.3%), and 2 in the form of Avasa and Arishta (8.4%) [ Table 2] Acharya Charaka has described 20 types of Prameha and treatment planned by categorizing the patients into two Table 2: Triphala containing formulations in ayurvedic texts [14‑23] Name of formulations References Ingredients Percentage of Triphala Indications as a antidiabetic agent Triphaladi Kwath C.S.Su. 23/10,11 Triphala + 7 30 Santarpanottha Prameha Triphala Kashaya C.S.Chi. 6/22 Triphala + 3 50 Santarpanajanya Prameha Triphala Kwath C.S.Chi. 6/26 Triphala + 3 50 Prameha Nashak Phalatrikadi Kwath C.S.Chi. 6/40 Triphala + 4 42.85 Sarvapramehahar Madhvasava C.S.Chi. 6/41‑44 Triphala + 27 10 In Kapha‑pittaj Prameha Triphala Rasa C.S.Chi. 6/46 Triphala 100 Udakapan in Sarva prameha Triphaladi Kshaar C.S.Chi. 15/188‑193 Triphala + 27 10 Pramehahar Triphala Churna S.S.Su. 38/57 Triphala 100 Pramehahar Triphala Kwath S.S.Chi. 11/8 Triphala + 3 50 Sarvapramehahar Triphala Kwath S.S.Chi. 11/8 Triphala + 2 60 Phenamehahar Triphala Kwath S.S.Chi. 11/8 Triphala 100 Kshaarmeha nashaka Triphala Kashaya A. S. Su. 12/47 Triphala 100 Pramehahar Muskadi Kashaya A. S. Su. 16/26 Triphala + 7 30 Pramehahar Phenmehahar Kwath Vi. Ma. 35/8 Triphala + 2 60 Phen Mehahar Triphaladi Kwath Vi. Ma. 35/11‑13,19 Triphala + 3 50 Prameha har Nyogrodhadi Churna Vi. Ma. 35/24‑28 Triphala + 24 11.1 Vinshatimehahar Trikatvadi Gugglu Vi. Ma. 35/32‑33 Triphala + 8 27.3 Pramehahar Triphaladi Kashaya G. Ni. 30/46 Triphala + 2 60 Phen Mehahar Gokshur Gugglu Vatika G. Ni. 30/61‑62 Triphala + 5 37.5 Pramehahar Kushtadhya Churnam G. Ni. 30/77 Triphala + 7 30 Pramehjanya Vedanahar Shavadanstradhyam Churnam G. Ni. 30/78‑84 Triphala + 29 9.4 Pramehahar Triphaladi Kwath Chakradutta 35/6‑11 Triphala + 2 60 Phen Mehahar Triphaladi Kutajadishcha Chakradutta 35/19 Triphala + 3 50 Pramehahar C.S.Su.: Charaka Samhita Sutrasthana, C.S.Chi.: Charaka Samhita Chikitsasthana, S.S.Su.: Sushruta Samhita Sutrasthana, S.S.Chi.: Sushruta Samhita Chikitsasthana, A.S. Su.: Astanga Samgraha Sutrasthana, Vi. Ma.: Vrinda Madhava, G. Ni.: Gada Nigraha

[[[ p. 4 ]]]

[Summary: This page categorizes Prameha patients (stout vs. lean) and notes that many Triphala formulations are effective for all Prameha types. It attributes antidiabetic activity to the restoration of pancreatic function or inhibited glucose absorption. The page also highlights Triphala's antioxidant properties and its role as a Naimittika Rasayana.]

Shekhar, et al .: Triphala: An antidiabetic agent Asian Journal of Pharmaceutic s • Oct-Dec 2017 (Suppl) • 11 (4) | S 688 groups, i.e., Sthula Pramehee (stout built person) and Krisha Pramehee (lean built person). In the formulations mentioned above 14 (61.0%) are Sarvapramehahar (effective in all the Twenty types of Prameha), 4 (17.4%) are Phenmehahar, 2 (8.7%) in Santarpanjanya Prameha, and 1 (4.3%) in each Vata Kaphaja Prameha, Kshaar Meha and Pramehajanya Vedana [ Table 2]. Hence, it can be said that Triphala consists the potential to treat each and every type of Prameha or acting as an effective antidiabetic agent. Antidiabetic activity of the herbal drugs is mainly due to their ability to restore the functions of pancreatic tissues by causing an increase in insulin output or inhibit the intestinal absorption of glucose or to the facilitation of metabolites in insulin-dependent processes [31] As herbal drugs are a complex mixture of different phytoconstituents and these are one of the responsible factors along with pharmacological properties of that drug for a drug to perform its action. Individual drugs of Triphala contain glycosides, alkaloids, terpenoids, flavonoids, carotenoids, etc., and these all are frequently implicated to possess potential as antidiabetic [Table 1] [32] In different classical treatises, huge therapeutic properties of Triphala have been given and various research works have also been done in this regard to further validate the above consideration. Individual drugs of Triphala, i.e., Haritaki, Bibhitaki, and Amalaki exhibits wide range of medicinal properties especially antidiabetic properties. From the above aspects, it can be said that Triphala is one of the magic remedy in various ailments and specifically in Prameha . Different references are available for Triphala in different treatises. Barley soaked in Triphala Kashaya, kept overnight and then mixed with honey acts as a nourishing diet. Furthermore, Triphala along with Musta ( Cyperus rotundus ), Patha ( Cissampelos pareira ) mixed with honey has also been given. Moreover, it should be taken by the patient suffering from Prameha regularly to overcome the disease [33] Triphala as a whole is expected to be more effective due to the combined activity of the individual components. Antioxidant property of Triphala arises from the Polyphenols, which reduces the oxidative stress by converting the reactive oxygen free radicals to non-reactive products [34] Triphala are also the drugs said to act as Naimittika Rasayanas which is beneficial in Prameha . [35] Its potency as an anticancer drug, antibacterial, anti-inflammatory and in treatment of arthritis, stress, and cataract is all well studied and proven. As there is lot of adulteration and substitution in the herbal market more studies and parameters for Quality Control of the individual ingredients and the compound formulation Triphala needs to be established and carried out so as to ensure reliability and reproducibility of the formulation CONCLUSION As usage of herbal medicines is increasing worldwide, hence it can act as a medicinal boon at different stages of diabetes mellitus and also in complicated phases of diabetes mellitus. The study disclosed the avenue properly for evaluating the therapeutic efficacy as well as inbuilt potential of a common preparation “Triphala” which can on various ailments in a very effectively way but its antidiabetic potential can’t be undervalued REFERENCES 1. WHO Diabetes Programme. Complications of Diabetes. Available from: http:/www.WHO.int/diabetes/action_ online/basics/en/index 3.html 2. Rao NK, Nammi S. Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. Seeds in streptozotocin-induced diabetic rats. BMC Complement Altern Med 2006;6:17 3. Parasuraman S, Thing GS, Dhanaraj SA. Polyherbal formulation: Concept of ayurveda. Pharmacogn Rev 2014;8:73-80 4. Williamson EM. Major Herbs of Ayurveda. Philadelphia, PA: Churchill Livingstone; 2002. p. 210-4, 294-7, 298-301 5. Ferrara N. Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 2009;29:789-91 6. Murthy KR. Vagbhatta Astanga Hridaya. 4 th ed. Varanasi: Krishnadas Academy; 2000. p. 24 7. Vaidya BH, editor. Vagbhata Ashtanga Hridaya, Commentary by Arunadatta and Hemadri, Nidana Sthan 10/7. 9 th ed. Varanasi: Chowkhamba Sanskrit Series Office; 2005 8. Srinivas P. Diabetes mellitus (madhumeha)-an ayurvedic review. Int J Pharm Pharm Sci 2014;6:107-10 9. Agnivesha. Carakasamhitha with Ayurveda Deepika Commentary by Chakrapanidutta, Edited by Vaidya Yadavji Trikamji, Nidana Sthana 6/15. Varanasi: Chowkhambhakrishnadas Academy Publication; 2010. p. 446 10. Kamath S, Prasad UN. A clinical study evaluating the efficacy of Nisha Katakadi Kashaya in Madhumeha (diabetes mellitus). J Biol Sci Opin 2014;2:181-7 11. Wohlmuth H. Triphala-a short review. Inf Res Bot Med 2007;16:2 12. Kaur S, Micheal H, Arora S, Harkonen PL, Kumar S. The in vitro cytotoxic and apoptotic activity of Triphala-an Indian herbal drug. J Ethnopharmacol 1997;97:15-20 13. Sharma PV. Dravyaguna Vigyana. Vol. 1. Varanasi, India: Chaukhambha Bharti Academy; 1986. p. 239-41, 753-60 14. Samhita C, Agnivesh. Vidhyotini Hindi Commentary by Pt. Kashinath Pandey, Part-I, Sutrasthana. Ch. 10, 11, 23. Varanasi: Chaukhambha Bharati Academy; 2016. p. 437 15. Samhita C, Agnivesh. Vidhyotini Hindi Commentary by Pt. Kashinath Pandey, Part-II, Chikitsasthana. Ch. 6/22, 6/26, 6/40, 6/41-44, 6/46. Varanasi: Chaukhambha Bharati Academy; 2015. p. 236-1 16. Samhita AK. Vidhyotini Hindi Commentary by Pt. Kashinath Pandey, Part-II, Chikitsasthana. Ch. 15, 188- 193. Varanasi: Chaukhambha Bharati Academy; 2015.

[[[ p. 5 ]]]

[Summary: This page emphasizes the increasing use of herbal medicines and Triphala's potential in managing diabetes. It acknowledges the need for quality control studies due to adulteration in the herbal market. It also mentions that the conflicts of interest are none declared and the source of support is nil.]

Shekhar, et al .: Triphala: An antidiabetic agent Asian Journal of Pharmaceutic s • Oct-Dec 2017 (Suppl) • 11 (4) | S 689 p. 477 17. Samhita S, Sushruta M. Ayurveda Tatvasandipika Hindi Commentary by Kaviraj Ambikadutta Shastry, Part I, Chaukhambha Sanskrita Sansthana, Sutrasthana. Ch. 38-57. Varanasi: Chaukhambha Bharati Academy; 2014. p. 188 18. Samhita S, Sushruta M. Ayurveda Tatvasandipika Hindi Commentary by Kaviraj Ambikadutta Shastry, Part I, Chaukhambha Sanskrita Sansthana. Ch. 8-11. Varanasi: Chaukhambha Bharati Academy; 2014. p. 76 19. Sangraha A, Vagbhatta V. Saroja-Hindi Commentary by Dr. Ravi Dutta Tripathi, Chaukhambha Sanskrita Pratisthana, Sutrasthana. Ch. 12-47. Delhi: Chaukhambha Bharati Academy; 2015. p. 257 20. Sangraha A, Vagbhatta V. Saroja-Hindi Commentary by Dr. Ravi Dutta Tripathi, Chaukhambha Sanskrita Pratisthana, Sutrasthana. Ch. 16, 26. Delhi: Chaukhambha Bharati Academy Reprint; 2015. p. 319 21. Madhava V, Vrinda S. Edited and Translated by Dr. Premvati Tiwari, Chaukhambha Visvabharati. 1 st ed. Ch. 35/8, 35/11-13, 19, 35/24-28, 35/32-33. Varanasi: Chaukhambha Bharati Academy; 2007. p. 370-3 22. Nigraha G, Sodhala VD. Vidhyotini Hindi Commentary by Sri Indradeva Tripathi, Part-II, Chowkhamba Sanskrit Series Office. 1 st ed. Ch. 30/46, 30/61-62, 30/77, 30/78-84. Varanasi: Chaukhambha Bharati Academy; 1969. p. 670-6 23. Dutta C, Dutta C. Padartha Bodhini Hindi Commentary by VD. Ravidutta Shastry, Chaukhambha Surbharati Prakashan. Ch. 35/6-11. Varanasi: Chaukhambha Bharati Academy; 2006. p. 154 24. Murali YK, Chandra R, Murthy PS . Antihyperglycemic effect of water extract of dry fruits of Terminalia chebula in experimental diabetes mellitus. Indian J Clin Biochem 2004;19:202-4 25. Vaidya BD, Sharma RK. Caraka Samhita, Text with English Translation and Critical Exposition Based on Cakrapani Dutta Ayurveda Dipika. Chikitsa-Sthan. Cha. 1. Varanasi: Chowkhamba Sanskrit Series Office; 2000. p. 13 26. Faizal P, Suresh S, Satheesh Kumar R, Augusti KT. A study on the hypoglycemic and hypolipidemic effects of an ayurvedic drug Rajanyamalakadi in diabetic patients. Indian J Clin Biochem 2009;24:82-7 27. Tirtha SS. The Ayurveda Encyclopedia: Natural Secrets to Healing, Prevention and Longevity. Bayville, NY, USA: Ayurveda Holistic Center Press; 2000. p. 72-3 28. Jose JK, Kuttan R. Antioxidant activity of Emblica officinalis . J Clin Biochem Nutr 1995;19:63-70 29. Dhir H, Agarwal K, Sharma A, Talukder G. Modifying role of Phyllanthus emblica and ascorbic acid against nickel clastogenicity in mice. Cancer Lett 1991;59:9-18 30. Tirtha SS. The Ayurveda Encyclopaedia: Natural Secrets to Healing, Prevention and Longevity. Bayville, NY, USA: Ayurveda Holistic Center Press; 2004. p. 78 31. Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed 2012;2:320-30 32. Malviya N, Jain S, Malviya S. Antidiabetic potential of medicinal plants. Acta Pol Pharm 2010;67:113-8 33. Agnivesha, Samhita C. Chikitsasthana Edited by Vaidya Jadavji Trikamji Acharya, Chowkambha Orientalia. Varanasi: Chaukhambha Bharati Academy; 2011. p. 6, 22-9, 40 34. Naik GH, Priyadarsini KI, Bhagirathi RG, Mishra B, Mishra KP, Banavalikar MM, et al. In vitro antioxidant studies and free radical reactions of triphala, an ayurvedic formulation and its constituents. Phytother Res 2005;19:582-6 35. Akarshini AM, Aruna. Management of Madhumeha Janya Upadrava with special reference to diabetic nephropathy-a clinical study. Ayu 2014;35:378-83 Source of Support: Nil. Conflict of Interest: None declared.

Other Health Sciences Concepts:

[back to top]

Discover the significance of concepts within the article: ‘Triphala Described as an Antidiabetic Agent in Ayurveda Treatises: A Review’. Further sources in the context of Health Sciences might help you critically compare this page with similair documents:

Dosha, Ayurveda, Vata, Pitta, Kapha, Sushruta-samhita, Amalaki, Madhumeha, Haritaki, Triphala, Amla, Rasashastra, Prameha, Gadanigraha, Churna, Charakasamhita, Ashtangasamgraha, Chakradatta, Terminalia chebula, Emblica officinalis, Bibhitaki, Kaphapitta, Medicinal plant, Human body, Vital organ, Medical science, First line, Medicinal properties, Ancient literature, Traditional medicine, Diabetes mellitus, Herbal medicine, Digestive disturbance, Chronic stage, Uttar Pradesh, Ayurvedic system, Natural function, Main ingredient, Ayurvedic treatise, Terminalia bellerica, Oral administration, Banaras Hindu University, Quality Control, Therapeutic efficacy, Bhaishajya kalpana, Clinical condition, Urinary tract, Herbal Market, Brihatrayee, Nerve damage, Polyherbal formulation, Herbal formulation, Herbal Ingredient, Oxidative stress, Triphala Kwath, Chronic constipation, Triphala Churna, Cardiovascular disease, Dosha Vitiation, Ayurvedic text, Antioxidant property, Naimittika Rasayana, Antidiabetic activity, Antidiabetic Drug, First line of treatment, Triphala Kashaya, Lifestyle disorder, Aqueous extract, Normal functioning, Dosage form, Pharmacological action, Antidiabetic properties, Rasashastra and Bhaishajya Kalpana, Liver Function, Ulcerative colitis, Department of Rasashastra, Faculty of Ayurveda, Antidiabetic potential, Colon cleansing, Therapeutic activities, Ayurvedic herbal formulation, Respiratory tract, Blood glucose, Santarpanottha Prameha, Kwath, Dried fruit, Antidiabetic effect, Herbal drug, Institute of Medical Sciences, Sthoola prameha, Antidiabetic activities, Kidney damage, Metabolite, Traditional Ayurvedic formulation, Individual Drugs, Antidiabetic action, Liver Injury, Cholesterol Reduction, Therapeutic benefit, Antidiabetic agent, Synthetic drug, Normal value, Alpha cells, Reactive oxygen, Dry fruit, Health benefit, Pancreatic tissue, Antidiabetic formulation, Krisha Prameha, Urinary disorder, Detoxifying Agent, Single herb, Individual component, Diabetic rat, Insulin output, Eye damage, Bowel function, Classical treatise, Individual herbs, Hepatic abnormalities.

Let's grow together!

I humbly request your help to keep doing what I do best: provide the world with unbiased sources, definitions and images. Your donation direclty influences the quality and quantity of knowledge, wisdom and spiritual insight the world is exposed to.

Let's make the world a better place together!

Like what you read? Help to become even better: